Clinical and Radiographic Evaluation of Buckley\'s Formocresol, Aloe Vera, and EndoSequence: As Pulpotomy Medicaments in Primary Molars
Year: 2025
Type: article
Abstract: Aim: The aim of this in vivo study is to compare the clinical and radiographic success of Buckley's Formocresol (FC), Aloe vera, and EndoSequence as pulpotomy medicaments in primary molars.Materials and methods: A total of 39 vital primary molars were selected and assigned to three groups: Group I-Buckley's Formocresol, Group II-Aloe vera, Group III-EndoSequence.The clinical and radiographic success was evaluated using Zurn and Seale criteria.The data were statistically analyzed using the Chi-square test.Results: After 3 months, the overall success rate was 92.3% in the Buckley's Formocresol group and 100% in the Aloe vera and EndoSequence groups.After 6 months, the overall success rate was 84.6% in the Buckley's Formocresol group, 92.3% in the Aloe vera group, and 100% in the EndoSequence group.There was a nonsignificant difference in the overall success between the three groups after 3 and 6 months.Conclusion: The clinical and radiographic success rates of Buckley's Formocresol, Aloe vera, and EndoSequence as pulpotomy medicaments in primary molars showed similar efficacy after 6 months of evaluation, although the results were not statistically significant.This states that in spite of Buckley's Formocresol being a gold standard medicament used for pulpotomy procedures, Aloe vera, a herbal medicament, and a newer medicament, EndoSequence, can be used as clinically effective pulpotomy medicaments with fewer limitations compared to Buckley's Formocresol.
Authors: Sakshi S Jajoo, Shweta Chaudhary, Preetam Shah, Laxmi Lakade, Rucha Davalbhakta, Smita Patil
Institution: Bharati Vidyapeeth (Deemed to be University)
Language: English
Subfield: Oral Surgery
Field: Dentistry
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4413374385